ArticleJournal of experimental & clinical cancer research : CR2026
Correction: Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway.
Xiang Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.